The product registration in Rest of the World is a challenging task because the regions under it are not harmonized. CIS and Latin America regions come under semi-regulated market. These regions have somewhat harmonized their regulatory organization. The significance of an emerging market is increasing globally. It is important for pharmaceutical companies to be up-to-date with the latest regulatory development. Both the regions follow their regional checklist for Drug Product Registration. Latin America includes a group of countries like Brazil, Guatemala and Peru etc, Whereas CIS includes Russia, Ukraine, Uzbekistan, Armenia and Tajikistan etc.
Keywords: Generic Drug, Latin American regions, Regulatory requirements, Product Registration.